GSK2656157   Click here for help

GtoPdb Ligand ID: 9544

Synonyms: compound 6 [PMID: 24900593] | GSK-2656157
Compound class: Synthetic organic
Comment: GSK2656157 is an optimised, ATP-competitive inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK), designed using the structural scaffold of GSK2606414 [2]. Preclinical evaluation is reported in [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 1
Rotatable bonds 4
Topological polar surface area 89.93
Molecular weight 416.18
XLogP 2.77
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=C(N1CCc2c1ccc(c2F)c1cn(c2c1c(N)ncn2)C)Cc1cccc(n1)C
Isomeric SMILES O=C(N1CCc2c1ccc(c2F)c1cn(c2c1c(N)ncn2)C)Cc1cccc(n1)C
InChI InChI=1S/C23H21FN6O/c1-13-4-3-5-14(28-13)10-19(31)30-9-8-16-18(30)7-6-15(21(16)24)17-11-29(2)23-20(17)22(25)26-12-27-23/h3-7,11-12H,8-10H2,1-2H3,(H2,25,26,27)
InChI Key PRWSIEBRGXYXAJ-UHFFFAOYSA-N
Bioactivity Comments
In a screening panel of >300 kinases 10μM GSK2656157 inhibited only 17 kinases >80% [2]. GSK2656157 has an improved pharmacokinetic profile compared to GSK2606414 and exhibits antitumor and antiangiogenic activity in preclinical testing [1]
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
eukaryotic translation initiation factor 2 alpha kinase 3 Primary target of this compound Hs Inhibitor Inhibition 9.1 pIC50 - 2
pIC50 9.1 (IC50 8x10-10 M) [2]
Description: Biochemical activity